Clinical trial
A Multicenter Study to Evaluate and Characterize the Ex Vivo Effect of Pharmacological Chaperone Therapy in Blood Cell Lines Derived From Patients With Gaucher Disease
NCT00351156 is registered in ClinicalTrials.gov with Amicus Therapeutics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter Study to Evaluate and Characterize the Ex Vivo Effect of Pharmacological Chaperone Therapy in Blood Cell Lines Derived From Patients With Gaucher Disease
- Lead sponsor
- Amicus Therapeutics
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 31, 2006
- Completion date
- March 31, 2007
- Enrollment
- 50
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.